Literature DB >> 3301094

Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.

J P De Villartay, F Le Deist, C Griscelli, A Fischer.   

Abstract

We have studied immunological reconstitution following partially HLA-incompatible T cell depleted bone marrow transplantation, compared with reconstitution following HLA identical T cell depleted and HLA identical untreated bone marrow transplantation. We often observed an early emergence of E-rosette forming cells that were T3 negative and displayed strong natural killer activity in the first group of patients. This activity was shown with fresh leucocytes as well as interleukin 2 grown cells. The appearance of T3+ cells was delayed in this situation compared to that observed in HLA identical bone marrow transplantation. The delay in T3+ cell differentiation and in cellular immune function development probably explains why NK rosette forming cells are early detected within 3-4 months following HLA mismatched bone marrow transplantation. This NK subset is likely to be present at an early stage in all types of bone marrow transplantation, but is most commonly observed simultaneously with the T3+ cells in HLA identical untreated bone marrow transplantation. The respective role of T cell depletion and HLA incompatibility in this phenomenon are discussed while patients' conditioning, cyclosporine A and graft-versus-host disease have been shown to be irrelevant for the dissociation between NK E-rosette forming cells and T3+ subset onsets.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301094      PMCID: PMC1542578     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Lymphocyte dysfunction in chronic graft-versus-host disease.

Authors:  A Saxon; R E McIntyre; R H Stevens; R P Gale
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

3.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

4.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

5.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

6.  Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977.

Authors:  A B Kenny; W H Hitzig
Journal:  Eur J Pediatr       Date:  1979-06-28       Impact factor: 3.183

7.  Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting.

Authors:  M S Tsoi; R Storb; S Dobbs; K J Kopecky; E Santos; P L Weiden; E D Thomas
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

8.  Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.

Authors:  J P De Villartay; C Griscelli; A Fischer
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

9.  Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production.

Authors:  M Lipinski; J L Virelizier; T Tursz; C Griscelli
Journal:  Eur J Immunol       Date:  1980-04       Impact factor: 5.532

10.  Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.

Authors:  M C Dokhelar; J Wiels; M Lipinski; C Tetaud; A Devergie; E Gluckman; T Tursz
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.